JP Patent

JP7033143B2 — Ｄｃｔｎ１タンパク質とｒｅｔタンパク質との融合タンパク質

Assigned to Taiho Pharmaceutical Co Ltd · Expires 2022-03-09 · 4y expired

What this patent protects

Patent listed against Zelboraf.

Drugs covered by this patent

Patent Metadata

Patent number
JP7033143B2
Jurisdiction
JP
Classification
—
Expires
2022-03-09
Drug substance claim
No
Drug product claim
No
Assignee
Taiho Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.